Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
Background
Cited by
Items 701–800 of 999
Sun, M., Wang, S., Song, Q., Wang, Z., Wang, H., Dianxiu, N., Xu, B., Wei, Q., & Liu, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091751 · Cited by 11
Zeman, E. M., Schreiber, E. C., & Tepper, J. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00027-8 · Cited by 17
Analysis of Hypoxia and the Hypoxic Response in Tumor Xenografts
Böğürcü, N., Seidel, S., Garvalov, B. K., & Acker, T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7665-2_25 · Cited by 11
Dharmaiah, S., Zeng, J., Rao, V. S., Ouyang, Z., Ma, T., Yu, K., Bhatt, H., Shah, C., Godley, A. R., Xia, P., et al. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1660810 · Cited by 11
Molecular and Cellular Biology
Stevenson, M. A., & Calderwood, S. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00002-2 · Cited by 11
Protein aggregation and biomolecular condensation in hypoxic environments (Review)
Li, C., Hao, B., Yang, H., Wang, K., Fan, L., & Xiao, W. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5357 · Cited by 11
SiTu, J., Yang, Y., Zhang, L., Yan, H., & Cheng, Y. (2024) · RSC Advances · doi:10.1039/d4ra00497c · Cited by 10
Reactive Oxygen Species in Cancer
Ogidi, O. I., Erho, S. A., & Omu, O. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7919-6.ch010 · Cited by 14
Safronova, M. M., Colliez, F., Magat, J., Joudiou, N., Jordan, B. F., Raftopoulos, C., Gallez, B., & Duprez, T. P. J. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.10.021 · Cited by 10
“Oxygen deprivation within malignant tumors synergistically results from poor functionality of anarchic neovasculature with subsequent unstable blood supply [1] and from increased oxygen demands by proliferating cells [2,3].”
BackgroundLi, Q., Lin, Q., Kim, H., & Yun, Z. (2017) · Europe PMC (PubMed Central) · Cited by 13
Holmes, T. M., Brown, A. W., Suggitt, M., Shaw, L. A., Simpson, L., Harrity, J. P. A., Tozer, G. M., & Kanthou, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-66568-8 · Cited by 10
Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts
Wadsworth, B. J., Lee, C.-M., & Bennewith, K. L. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01691-5 · Cited by 9
Su, M., Ren, X., Du, D., He, H., Zhang, D., Xie, R., Deng, X., Zou, C., & Zou, H. (2023) · Japanese Journal of Radiology · doi:10.1007/s11604-023-01446-7 · Cited by 11
“HIF-1 regulates the expression of numerous genes through binding to DNA at hypoxia response elements and helps tumor cells adapt to hypoxic microenvironment, which promotes tumor progression, metastasis, and resistance to radiotherapy [34–38].”
BackgroundBurrell, J. S., Walker‐Samuel, S., Baker, L. C. J., Boult, J. K. R., Ryan, A. J., Waterton, J. C., Halliday, J., & Robinson, S. P. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22779 · Cited by 10
Speicher, P. J., Beasley, G. M., Jiang, B. S., Lidsky, M. E., Palmer, G. M., Scarbrough, P. M., Mosca, P. J., Dewhirst, M. W., & Tyler, D. S. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3222-0 · Cited by 10
Self-citationSridharan, P., Vinothkumar, G., Pratheesh, P., & Babu, K. S. (2018) · New Journal of Chemistry · doi:10.1039/c8nj00097b · Cited by 11
Statins reduce testicular and ocular VEGF: A potential compromise to microcirculation
Ekerbiçer, N., Gürpınar, T., Şişman, A. R., Güvendi, G., Çamsarı, U. M., & Uysal, N. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.04.006 · Cited by 12
Quantification of spatial pharmacogene expression heterogeneity in breast tumors
Powell, N. R., Silvola, R. M., Howard, J. S., Badve, S., Skaar, T. C., & Ipe, J. (2022) · Cancer Reports · doi:10.1002/cnr2.1686 · Cited by 9
Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical Translation
Adebayo, A. K., & Nakshatri, H. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2311 · Cited by 12
Molecular and functional imaging of invasion and metastasis: Windows into the metastatic cascade
Stasinopoulos, I. A., Penet, M., Krishnamachary, B., & Bhujwalla, Z. M. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2010-0188 · Cited by 10
Survival in Acute and Severe Low O2 Environment: Use of a Genetic Model System
Azad, P., & Haddad, G. G. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05045.x · Cited by 13
Li, B.-Q., Dong, X., Li, N., Gao, J.-Y., Yuan, Q., Fang, S.-H., Gong, X., Wang, S., & Wang, F. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532598 · Cited by 10
Burrell, J. S., Walker‐Samuel, S., Baker, L. C. J., Boult, J. K. R., Jamin, Y., Ryan, A. J., Waterton, J. C., Halliday, J. L., & Robinson, S. P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27460 · Cited by 10
Plotkin, B. J., Davis, J. W., Strizzi, L., Lee, P., Christoffersen-Cebi, J., Kacmar, J., Rivero, O. J., Elsayed, N., Zanghi, N., Ito, B., et al. (2017) · Tissue and Cell · doi:10.1016/j.tice.2017.12.004 · Cited by 10
Hypoxia imaging in upper gastrointestinal tumors and application to radiation therapy
Tao, R., Ager, B. J., Lloyd, S. A. J., Torgeson, A. M., Denney, M., Gaffney, D. K., Kharofa, J. R., Lin, S. H., Koong, A. C., Anzai, Y., et al. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2018.09.15 · Cited by 10
Epithelial-Mesenchymal Transition in Tumor Microenvironment Induced by Hypoxia
Eskiizmir, G., & Özgür, E. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78717 · Cited by 13
Abou‐Shanab, A. M., Gaser, O. A., Galal, N., Mohamed, A. M., Atta, D., Kamar, S. S., Magdy, S., Khedr, M. A., Elkhenany, H. A., & El‐Badri, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-89884-3 · Cited by 11
“While research has established that factors beyond hypoxia can stabilize HIF-1α, the influence of chemotherapies on HIF-1α levels within normoxic cancer cells remains largely unknown 51 .”
The effect of single bout and prolonged aerobic exercise on tumor hypoxia in mice
Elming, P. B., Busk, M., Wittenborn, T. R., Bussink, J., Horsman, M. R., & Lønbro, S. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00561.2022 · Cited by 9
Chen, Y., Gao, R., Jing, D., Shi, L., Kuang, F., & Jing, R. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124030 · Cited by 11
Tumor suppressor p53 stole the AKT in hypoxia
Yun, Z., & Glazer, P. M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82058 · Cited by 10
Vascular Magnetic Resonance Imaging in Brain Tumors During Antiangiogenic Therapy—Are We There Yet?
Gerstner, E. R., Emblem, K. E., & Sorensen, A. G. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000128 · Cited by 9
Jansen, J., Vieten, P., Pagliari, F., Hanley, R., Marafioti, M. G., Tirinato, L., & Seco, J. C. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.597635 · Cited by 9
Bone Marrow-Derived Cells in GBM Neovascularization
Bergers, G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_31 · Cited by 11
Ruiz‐Saurí, A., Valencia-Villa, G., Am, R., Pérez, J., García, R., García, H. D., Benavent, J., Sancho‐Tello, M., Cardá, C., & Llombart‐Bosch, A. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0072-7 · Cited by 9
Molecular and Cellular Biology
Stevenson, M. A., & Calderwood, S. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1637-5.00002-x · Cited by 9
Epel, B., & Halpern, H. J. (2017) · Wiley eBooks · doi:10.1002/9780470034590.emrstm1512 · Cited by 10
Proteome capacity constraints favor respiratory ATP generationPreprint
Shen, Y., Dinh, H. V., Cruz, E. R., Call, C. M., Baron, H., Ryseck, R.-P., Pratas, J., Subramanian, A. M., Fatma, Z., Weilandt, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.10.503479 · Cited by 9
Sobti, A., Skinner, H. D., & Wilke, C. T. (2025) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2025.02.008 · Cited by 12
Tang, W., Huang, K.-J., Xu, J., Cai, Q., Song, Y.-P., Fan, T.-Q., Zhang, Y., Liu, T., & Li, Y. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01431-x · Cited by 15
Redox Potential Dependence of Peptide Structure Studied Using Surface Enhanced Raman Spectroscopy
Ochsenkühn, M. A., Borek, J. A., Phelps, R. G., & Campbell, C. J. (2011) · Nano Letters · doi:10.1021/nl200885p · Cited by 8
Menisy, G. M., Zakaria, S., & Suddek, G. M. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109268 · Cited by 8
Distribution-informed and wavelength-flexible data-driven photoacoustic oximetry
Gröhl, J., Yeung, K., Gu, K., Else, T. R., Golinska, M. A., Bunce, E. V., Hacker, L., & Bohndiek, S. E. (2024) · Journal of Biomedical Optics · doi:10.1117/1.jbo.29.s3.s33303 · Cited by 12
Cancer Therapy Combining High-Intensity Focused Ultrasound and Megavoltage Radiation
Borasi, G., Melzer, A., Russo, G. I., Nahum, A. E., Qinghui, Z., Alongi, F., Vicari, F., & Gilardi, M. C. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.03.025 · Cited by 8
Potential role of the glycolytic oscillator in acute hypoxia in tumors
Fru, L. C., Adamson, E. B., Campos, D. D., Fain, S. B., Jacques, S. L., van der Kogel, A. J., Nickel, K. P., Song, C., Kimple, R. J., & Kissick, M. W. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/24/9215 · Cited by 9
Kim, W., Park, A., Jang, H. H., Kim, S.-E., & Park, K. (2022) · Cancers · doi:10.3390/cancers14194711 · Cited by 8
Pressure Gradients in Solid Tumors
Stapleton, S., & Milosevic, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_9 · Cited by 12
Muscari, C., Giordano, E., Bonafè, F., Govoni, M., Pasini, A., & Guarnieri, C. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.022 · Cited by 9
Ding, Y., Qin, Q., Yang, Y., Sun, X., Yang, X., Zhu, H., Chen, X., Zhang, H., Yang, Y., Gao, L., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.5247 · Cited by 9
Hypoxia-activated cytotoxicity of benznidazole against clonogenic tumor cells
Li, Q., Lin, Q., & Yun, Z. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1250988 · Cited by 8
van Beek, H. (2018) · F1000Research · doi:10.12688/f1000research.15635.2 · Cited by 9
Direct and indirect assessment of cancer metabolism explored by MRI
Kishimoto, S., Oshima, N., Krishna, M. C., & Gillies, R. J. (2018) · NMR in Biomedicine · doi:10.1002/nbm.3966 · Cited by 8
AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC
Göttgens, E., Bussink, J., Ansems, M., Hammond, E. M., & Span, P. N. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.04.048 · Cited by 8
McCarthy, N. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2577 · Cited by 8
Xu, E., Huang, Z. Y., Zhu, K., Hu, J., Ma, X., Wang, Y., Zhu, J., & Zhang, C. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111501 · Cited by 9
Pan, X., Liao, M., Ma, H., Jiang, X., Huang, H., Wei, M., & Li, Q. (2021) · BioMed Research International · doi:10.1155/2021/3834040 · Cited by 7
Kim, C. H., Lee, J. H., Lee, J. W., Kim, E.-J., & Choi, S. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28023 · Cited by 10
Photodynamic Therapy for X-ray-Induced Radiation-Resistant Cancer Cells
Ito, H., Shoji, Y., Ueno, M., Matsumoto, K., & Nakanishi, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112536 · Cited by 7
“We are currently investigating these effects in detail in animal models.”
Wang, J., Wang, R., Li, N., Shen, X. H., Huang, G., Zhu, J., & He, D. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s155509 · Cited by 7
Boss, M., Oberley‐Deegan, R. E., Batinic̈‐Haberle, I., Talmon, G. A., Somarelli, J. A., Xu, S., Kosmacek, E. A., Griess, B., Mir, S. U. R., Shrishrimal, S., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00109.1 · Cited by 11
Self-citationGuo, R., Liu, Y., Xu, N., Ling, G., & Zhang, P. (2022) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2022.03.002 · Cited by 9
Yuan, M., Zhai, Y., & Hui, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.978608 · Cited by 9
You, P., Liu, S., Li, Q., Xie, D., Yao, L., Guo, C., Guo, Z., Wang, T., Qiu, H., Guo, Y., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05304-x · Cited by 7
“…microvascular damage, which may increase mesenchymal transition and metastasis in some tumor cells or induce generation of cancer stem cell-like cells; this epigenetic reprogramming mechanism has also been demonstrated in a radiation-resistant model of pancreatic cancer (Dewhirst et al. 2008).”
BackgroundWang, K. S., Ma, J., Mi, C., Li, J., Lee, J. J., & Jin, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4576 · Cited by 7
Jiang, X., & Tomlinson, I. P. M. (2020) · Open Biology · doi:10.1098/rsob.190297 · Cited by 7
“There is also evidence the cycling hypoxia is rather complex with at least two dominant time-scales, which vary between hours and days [24].”
BackgroundPalmer, G. M., Zhang, H., Lee, C.-T., Mikati, H., Herbert, J. A., Krieger, M., von Windheim, J. A., Koester, D., Stevenson, D. S., Rocke, D. J., et al. (2018) · Journal of Biomedical Optics · doi:10.1117/1.jbo.23.5.057004 · Cited by 10
Self-citationPhotodynamic therapy-driven induction of suicide cytosine deaminase gene
Bil, J., Wlodarski, P. K., Winiarska, M., Kurzaj, Z., Issat, T., Józkowicz, A., Wegiel, B., Dulak, J., & Gołąb, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.012 · Cited by 7
Fractionation Effects in Clinical Practice
Bentzen, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5897-7.00003-2 · Cited by 7
Eswaran, H., Kasthuri, R. R., Bendapudi, P. K., Khorana, A. A., Kasthuri, R. S., van Es, N., & Grover, S. P. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025018001 · Cited by 6
Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment
KHAN, I. A., Fang, Q., Fei, C., Wang, Z., Chen, Z., Chen, G., Xu, Z., Xu, S., & Chen, Z. (2025) · BMEMat · doi:10.1002/bmm2.70041 · Cited by 10
Discovery of the Hypoxia-Activated Prodrug SN30000
Hay, M. P., Hicks, K. O., & Wilson, W. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12450-3 · Cited by 7
Hypoxia-dependent recruitment of error-prone DNA polymerases to genome replication
Yehuda, R., Dromi, I., Levin, Y., Carell, T., Geacintov, N. E., & Livneh, Z. (2024) · Oncogene · doi:10.1038/s41388-024-03192-0 · Cited by 7
Isoforms of autophagy-related proteins: role in glioma progression and therapy resistance
Belyaeva, E. D., Kharwar, R. K., Ulasov, I. V., Karlina, I., Timashev, P. S., Mohammadinejad, R., & Acharya, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04308-w · Cited by 6
Barrera, J. C. A., Ondo-Méndez, A., Giera, M. A., & Kostidis, S. (2023) · Metabolites · doi:10.3390/metabo13070875 · Cited by 6
Fluorescence and reflectance spectral imaging system for a murine mammary window chamber model
Leung, H. M., & Gmitro, A. F. (2015) · Biomedical Optics Express · doi:10.1364/boe.6.002887 · Cited by 6
Abdel–Wahab, M., Schally, A. V., Rick, F. G., Szalontay, L., Block, N. L., Jordà, M., Mahmoud, O., Markoe, A. M., Shi, Y.-F., Reiner, T., et al. (2012) · Journal of Radiation Oncology · doi:10.1007/s13566-012-0031-1 · Cited by 6
Targeting Tumoral Hypoxia: Finding Opportunity in Complexity
Dhani, N. C., & Milosevic, M. (2012) · Future Oncology · doi:10.2217/fon.12.100 · Cited by 7
Redox activated polymeric nanoparticles in tumor therapy
Alimoradi, H., Matikonda, S. S., Gamble, A. B., Giles, G. I., & Griesh, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00010-5 · Cited by 7
Sense and Sensibility of Oxygen in Pathophysiology Using EPR Oximetry
Kuppusamy, P. (2020) · Biological magnetic resonance · doi:10.1007/978-3-030-47318-1_9 · Cited by 10
Skwarski, M., Bowler, E., Wilson, J. D., Higgins, G. S., & Hammond, E. M. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_11 · Cited by 7
Xu, Z., Zhang, B., Liao, Z., & Gou, S.-H. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116214 · Cited by 6
Elming, P. B., Wittenborn, T. R., Busk, M., Sørensen, B. S., Thomsen, M. B. H., Strandgaard, T., Dyrskjøt, L., Nielsen, S., & Horsman, M. R. (2021) · Cancers · doi:10.3390/cancers13112602 · Cited by 6
Lausch, A., Chen, J., Ward, A. D., Gaede, S., Lee, T., & Wong, E. (2014) · Physics in Medicine and Biology · doi:10.1088/0031-9155/59/22/7039 · Cited by 6
Rodrigo-Martínez, P., Barros, M., Terencio, M. C., Garrido, E., Arroyo, P., Saez, J. A. D. S., Parra, M., & Gaviña, P. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01950-5 · Cited by 10
Wang, 迪. D. 王., Jin, K., Ying, C., Li, B., Zhang, G., Li, J., Chen, L., Chao, M., & Hu, X. (2026) · Oncogene · doi:10.1038/s41388-026-03836-3 · Cited by 5
Mesny, E., Leporq, B., Chapet, O., & Beuf, O. (2024) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.13626 · Cited by 5
Chou, C.-C., Chandramouli, G. V. R., Shin, T., Devasahayam, N., McMillan, A. B., Babadi, B., Gullapalli, R. P., Krishna, M. C., & Zhuo, J. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.10.029 · Cited by 7
Xu, Y., Zhu, K., Wu, J., Zheng, S., Zhong, R., Zhou, W., Cao, Y., Liu, J., & Wang, H. (2023) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2023.2276768 · Cited by 5
“The main issue of RT is that it fails to alleviate the problem of tumour hypoxia, leading to a series of subsequent events [23,24].”
Self-citationAzobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates
Xiao, D., Liu, L., Xie, F., Dong, J., Wang, Y., Xu, X. M., Zhong, W., Deng, H., Zhou, X., & Li, S. (2024) · Angewandte Chemie · doi:10.1002/ange.202310318 · Cited by 6
Progression of unfolded protein response and ferroptosis in angiogenesis
He, B., Hu, Y., Cao, Q., Li, Y., Tang, Y., Cao, T., Zhou, X., & Liu, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116354 · Cited by 9
Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression
Conte, M., Cabeza-Fernández, V., Oliver, F. J., Alarcón, T., & Soler, J. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00453-2 · Cited by 5
“This phenomenon has been quanti fi ed in tumors and has been correlated with poor prognosis and resistance to treatment 7,8 .”
BackgroundHypoxia and the DNA Damage Response
Olcina, M. M., & Hammond, E. M. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_2 · Cited by 8
Hypoxia, Metastasis, and Antiangiogenic Therapies
Siemann, D. W., Dai, Y., & Horsman, M. R. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_9 · Cited by 5
Prognostic value of HIF-1α expression during fractionated irradiation
Helbig, L., Yaromina, A., Sriramareddy, S. N., Böke, S., Koi, L., Thames, H. D., Baumann, M. A., & Zips, D. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0150-z · Cited by 6
2-18F-Fluoroethanol Is a PET Reporter of Solid Tumor Perfusion
Wadsworth, B. J., Pan, J., Dude, I., Colpo, N., Bosiljcic, M., Lin, K., Bénard, F., & Bennewith, K. L. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183624 · Cited by 5
ATF4, Hypoxia and Treatment Resistance in Cancer
Singleton, D. C., & Harris, A. L. (2019) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-05067-2_4 · Cited by 7
Shimizu, Y., Kudo, K., Kameda, H., Harada, T., Fujima, N., Toyonaga, T., Tha, K. K., & Shirato, H. (2019) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.mp.2019-0049 · Cited by 5
Test Structures for Developing Packaging for Implantable Sensors
Blair, E. O., Buchoux, A., Tsiamis, A., Dunare, C. C., Marland, J. R. K., Gray, M., Terry, J. G., Smith, S., & Walton, A. J. (2020) · IEEE Transactions on Semiconductor Manufacturing · doi:10.1109/tsm.2020.2987134 · Cited by 5
Mboge, M. Y., & Bissell, M. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165960 · Cited by 6
Nakhla, S. F., Rahawy, A., Salam, M. A. E., Shalaby, T., Zaghloul, M. S., & El-Abd, E. A. (2020) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2020.3028562 · Cited by 5
Mozafari, F., Rashidzadeh, H., Ghaffarlou, M., Salehiabar, M., Ertaş, Y. N., Ramazani, A., Abazari, M., Rahmati, M.-A., Javed, Y., Sharma, S. K., et al. (2022) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-031-04071-9_10 · Cited by 10
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.